Dr. Kathryn Anne Walker is a pharmacist who is specialized in Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in Baltimore, Maryland. Patients can reach her at 201 E University Pkwy, 33rd St Bldg, Suite 415, Baltimore or contact her on 410-554-2923. Active license number of Dr. Kathryn Anne Walker is 16410 for Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in Maryland. Dr. Kathryn Anne Walker is pharmacist Clinician/Clinical Pharmacy Specialist is a pharmacist with additional training and an expanded scope of practice that may include prescriptive authority, therapeutic management, and disease management.
Complete Profile:
Dr. Kathryn Anne Walker speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
201 E University Pkwy, 33rd St Bldg, Suite 415, Baltimore, Maryland, 21218-2829
Phone:
410-554-2923
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Kathryn Anne Walker are as mentioned below.
NPI Number:
1508106535
NPI Enumeration Date:
28 Feb, 2013
NPI Last Update On:
28 Feb, 2013
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Kathryn Anne Walker are as mentioned below.
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
8005 Garden Gate Ct, Ellicott City, Maryland
Zip:
21043-6793
Phone Number:
410-375-3699
Fax Number:
--
Patients can reach Dr. Kathryn Anne Walker at 201 E University Pkwy, 33rd St Bldg, Suite 415, Baltimore, Maryland or can call on phone at 410-554-2923.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.